In VITAL, daily vitamin D3 did not lower heart attacks, strokes, or heart deaths over five years. See what that means and how Renew uses vitamin D.

# Vitamin D and Heart Health: What the VITAL Trial Found

In the VITAL trial of 25,871 adults, daily vitamin D3 did not lower major cardiovascular events over a median of 5.3 years compared with placebo. Renew tests your vitamin D level and corrects a measured deficiency, and we don't prescribe vitamin D to prevent heart attacks when your level is already in range.

This page expands the vitamin D section of our [evidence guide to heart supplements](https://www.renewhealth.us/evidence/supplements-cardiovascular-health).

<!-- @image
type: chart
title: "VITAL: vitamin D3 vs placebo"
alt: "In the VITAL trial, hazard ratios for vitamin D3 vs placebo sat near 1.0 for major cardiovascular events, heart attack, stroke and cardiovascular death, and none differed from placebo."
attribution: "Created with BioRender.com (Industry)."
description: "Forest-style points from the page: 0.97, 0.96, 0.95, 1.11, reference line at 1.0, no confidence intervals. BioRender Industry artwork (custom figure session a56b5577-1d83-4c52-974f-c51e463be005) composed with Renew brand type and colors in DM Sans. Do not regenerate."
outputName: vitamin-d-vital-hazard-ratios
-->

## When the question comes up

A routine panel flags your vitamin D as low. You start a capsule and wonder if it's also protecting your heart. VITAL was designed to test exactly that question.

## What VITAL found

VITAL randomly assigned men 50 and older and women 55 and older, none with heart disease or cancer at the start, to daily vitamin D3 or placebo. [(Manson et al., *New England Journal of Medicine*, 2019, PMC6425757)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6425757/)

- Major cardiovascular events: hazard ratio 0.97, not significant
- Heart attack: 0.96
- Stroke: 0.95
- Cardiovascular death: 1.11
- Death from any cause: 0.99

None of these differed from placebo. High calcium levels and kidney stones were no more common with vitamin D than with placebo.

## What VITAL doesn't settle

Among participants with a baseline blood test, 12.7% started below 20 ng/mL. The trial found no significant difference in effect by baseline characteristics. It found no significant heart benefit in people who started low. The trial tested one dose. The authors note that a trial in people with extremely low levels might show a stronger effect.

## How Renew uses vitamin D

Renew uses vitamin D to correct a measured low level. We test 25-hydroxy vitamin D in our labs. We check your level and, if it's low, bring it up and retest. We treat the measured level. We don't present vitamin D as heart attack prevention.

[Magnesium](https://www.renewhealth.us/evidence/magnesium-heart-health) is another level we check before we treat.

## Sources

- Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. *New England Journal of Medicine*, 2019. [PMC6425757](https://pmc.ncbi.nlm.nih.gov/articles/PMC6425757/)

## Next step

A [CIMT scan](https://www.renewhealth.us/cimt) shows your artery wall. Renew offers it for $389 one-time. A clinician reviews the images with you. Book your CIMT.
